309P Pneumonitis and Corticosteroid Treatment in Patients with Unresectable Non-Small Cell Lung Cancer Receiving Durvalumab Consolidation after Definitive Chemoradiotherapy

S. Murata,H. Horinouchi, M. Morishita, S. Kaku,Y. Shinno,Y. Okuma, T. Yoshida,Y. Goto,N. Yamamoto,K. Okuma,M. Kusumoto,Y. Ohe

Annals of oncology（2022）

引用 0|浏览3

暂无评分

摘要

Durvalumab consolidation after definitive chemoradiotherapy (CRT) is the standard of care for locally advanced, unresectable non-small cell lung cancer (NSCLC). Clinicopathological features of pneumonitis and its treatment using corticosteroid have not been adequately investigated.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要